KNSA

Kiniksa Pharmaceuticals Internat…

• TipRanks·03/14 12:11

  Analysts Offer Insights on Healthcare Companies: CareCloud (CCLD) and Kiniksa Pharmaceuticals (KNSA)

• TipRanks·03/11 00:23

  Kiniksa Pharmaceuticals Earnings Call Highlights ARCALYST Surge

• Simply Wall St·03/06 21:24

  A Look At Kiniksa Pharmaceuticals International’s Valuation After Strong 2025 Growth And ARCALYST Commercial Momentum

• Reuters·03/04 21:41

  Kiniksa Pharmaceuticals CMO John F. Paolini Disposes of Common Shares

• Simply Wall St·03/04 16:29

  How Investors Are Reacting To Kiniksa (KNSA) Turning ARCALYST Revenue Into Full-Year Profitability And Flexibility

• Simply Wall St·02/27 05:29

  Is Kiniksa Pharmaceuticals (KNSA) Still Attractive After A 114% One-Year Share Price Surge?

• TipRanks·02/26 13:40

  Analysts’ Top Healthcare Picks: Acadia Healthcare (ACHC), Kiniksa Pharmaceuticals (KNSA)

• TipRanks·02/26 09:50

  Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), BioMarin Pharmaceutical (BMRN) and Kiniksa Pharmaceuticals (KNSA)

• Simply Wall St·02/26 03:42

  Kiniksa Pharmaceuticals International (KNSA) Profitability Shift Tests Bullish High Growth Narratives

• Reuters·02/25 21:02

  Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference

• Benzinga·02/25 18:00

  The Analyst Verdict: Kiniksa Pharmaceuticals In The Eyes Of 4 Experts

• Dow Jones·02/25 15:04

  Kiniksa Pharmaceuticals Is Maintained at Overweight by Wells Fargo

• Dow Jones·02/25 15:04

  Kiniksa Pharmaceuticals Price Target Raised to $53.00/Share From $50.00 by Wells Fargo

• Benzinga·02/25 14:54

  Wells Fargo Maintains Overweight on Kiniksa Pharmaceuticals, Raises Price Target to $53

• Dow Jones·02/25 13:33

  Kiniksa Pharmaceuticals Is Maintained at Outperform by Wedbush